↓ Skip to main content

In vitro priming of tumor-specific cytotoxic T lymphocytes using allogeneic dendritic cells derived from the human MUTZ-3 cell line

Overview of attention for article published in Cancer Immunology, Immunotherapy, February 2006
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (94th percentile)
  • Good Attention Score compared to outputs of the same age and source (77th percentile)

Mentioned by

patent
28 patents

Citations

dimensions_citation
50 Dimensions

Readers on

mendeley
80 Mendeley
Title
In vitro priming of tumor-specific cytotoxic T lymphocytes using allogeneic dendritic cells derived from the human MUTZ-3 cell line
Published in
Cancer Immunology, Immunotherapy, February 2006
DOI 10.1007/s00262-006-0142-x
Pubmed ID
Authors

Saskia J. A. M. Santegoets, Marco W. J. Schreurs, Allan J. Masterson, Ying Poi Liu, Steffen Goletz, Hans Baumeister, Esther W. M. Kueter, Sinéad M. Lougheed, Alfons J. M. van den Eertwegh, Rik J. Scheper, Erik Hooijberg, Tanja D. de Gruijl

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 80 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
India 2 3%
United Kingdom 1 1%
Netherlands 1 1%
Ireland 1 1%
Unknown 75 94%

Demographic breakdown

Readers by professional status Count As %
Researcher 28 35%
Student > Ph. D. Student 12 15%
Student > Bachelor 8 10%
Student > Master 7 9%
Other 4 5%
Other 8 10%
Unknown 13 16%
Readers by discipline Count As %
Agricultural and Biological Sciences 30 38%
Immunology and Microbiology 13 16%
Medicine and Dentistry 12 15%
Biochemistry, Genetics and Molecular Biology 8 10%
Social Sciences 1 1%
Other 1 1%
Unknown 15 19%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 12. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 January 2024.
All research outputs
#2,570,445
of 23,549,388 outputs
Outputs from Cancer Immunology, Immunotherapy
#136
of 2,942 outputs
Outputs of similar age
#8,520
of 157,580 outputs
Outputs of similar age from Cancer Immunology, Immunotherapy
#2
of 18 outputs
Altmetric has tracked 23,549,388 research outputs across all sources so far. Compared to these this one has done well and is in the 88th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,942 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.2. This one has done particularly well, scoring higher than 94% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 157,580 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 94% of its contemporaries.
We're also able to compare this research output to 18 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 77% of its contemporaries.